| SearchStrings |
| 1 | 7533 | 75.17 | &esrc=s |
| 2 | 122 | 1.22 | tropical journal of pharmaceutical resea... |
| 3 | 61 | 0.61 | drug release study of suppositories |
| 4 | 59 | 0.59 | tjpr |
| 5 | 28 | 0.28 | tropical journal of |
| 6 | 22 | 0.22 | 1 |
| 7 | 20 | 0.20 | pharmaceutical validation |
| 8 | 17 | 0.17 | http://www.tjpr.org/vol13_no2/2014_13_2_... |
| 9 | 16 | 0.16 | development and optimization of insulin-... |
| 10 | 13 | 0.13 | effects of potassium in oil and yields o... |
| 11 | 13 | 0.13 | nanotechnolgy of cosmetics and drug deli... |
| 12 | 12 | 0.12 | cache:http://www.tjpr.org/index.php?q=ca... |
| 13 | 12 | 0.12 | piper crocatum |
| 14 | 12 | 0.12 | http://www.tjpr.org/vol13_no2/2014_13_2_... |
| 15 | 10 | 0.10 | 2 |
| 16 | 10 | 0.10 | research how wealth influences with addi... |
| 17 | 10 | 0.10 | tropical journal |
| 18 | 9 | 0.09 | alginate beads of metformin hydrochlorid... |
| 19 | 9 | 0.09 | positive and negative zeta potential in ... |
| 20 | 9 | 0.09 | ficus pseudopalma blanco in tagalog |
| 21 | 9 | 0.09 | physicochemical charactaeristics supposi... |
| 22 | 8 | 0.08 | http://www.tjpr.org/jmanager/manuscript/... |
| 23 | 8 | 0.08 | "moisture""pressure sensitive adhesive" |
| 24 | 8 | 0.08 | http://www.tjpr.org/vol13_no2/2014_13_2_... |
| 25 | 8 | 0.08 | evaluation of antifungal activity pdf |
| 26 | 8 | 0.08 | http://www.tjpr.org/ |
| 27 | 7 | 0.07 | what is stability indicating method in h... |
| 28 | 7 | 0.07 | tropical j of pharma research |
| 29 | 7 | 0.07 | bacterial flora of wound 2013 pdf |
| 30 | 7 | 0.07 | causes of low c3 and c4 |
| 31 | 7 | 0.07 | http://www.tjpr.org/vol13_no2/2014_13_2_... |
| 32 | 7 | 0.07 | http://www.tjpr.org/vol12_no5/2013_12_5_... |
| 33 | 7 | 0.07 | keller kiliani |
| 34 | 6 | 0.06 | http://www.tjpr.org/vol1%20no2/okhamafe1... |
| 35 | 6 | 0.06 | composition of high fat diet used in nig... |
| 36 | 6 | 0.06 | procedure of estimation acidty from pota... |
| 37 | 6 | 0.06 | serum c3 and c4 levels |
| 38 | 6 | 0.06 | tropical pharmacology journal |
| 39 | 6 | 0.06 | miicrospheres formulation |
| 40 | 6 | 0.06 | validation in pharma |
| 41 | 6 | 0.06 | antidiabetic hypoglycemic antihyperlipid... |
| 42 | 6 | 0.06 | controlled release coated tablet pdf |
| 43 | 6 | 0.06 | tropical journal of pharmaceutical scien... |
| 44 | 6 | 0.06 | orodispersible tablet pdf |
| 45 | 6 | 0.06 | transdermal drug delivery review |
| 46 | 6 | 0.06 | low c3 and c4 |
| 47 | 6 | 0.06 | trop j pharm res |
| 48 | 6 | 0.06 | eudragit rs100 sustained release microsp... |
| 49 | 6 | 0.06 | pharmaceutical nano technology pdf |
| 50 | 5 | 0.05 | antimicrobial activity of medicinal plan... |
| 51 | 5 | 0.05 | tropical journal of pharmaceutical |
| 52 | 5 | 0.05 | chitosan low medium high |
| 53 | 5 | 0.05 | hygrophila spinosa |
| 54 | 5 | 0.05 | low molecular weight chitosan |
| 55 | 5 | 0.05 | chitosan low medium high |
| 56 | 5 | 0.05 | wood extract cancer treatment |
| 57 | 5 | 0.05 | crude leaf extract preperation of pandan... |
| 58 | 5 | 0.05 | isaac karimi |
| 59 | 5 | 0.05 | qa validation in pharmacy pdf |
| 60 | 5 | 0.05 | nanotechnology in drug delivery |
| 61 | 5 | 0.05 | tropical j of pharmaceutical research |
| 62 | 5 | 0.05 | nanotechnology in drug delivery and drug... |
| 63 | 4 | 0.04 | 12a9b620d3b599afc6949893674e6c90 |
| 64 | 4 | 0.04 | serum complement levels |
| 65 | 4 | 0.04 | medicinal uses of artocarpus altilis |
| 66 | 4 | 0.04 | idea; properties of drug candidate for t... |
| 67 | 4 | 0.04 | cleansing cream |
| 68 | 4 | 0.04 | hplc method for oxicam |
| 69 | 4 | 0.04 | pharmaceutical validation information |
| 70 | 4 | 0.04 | cisplatin nephrotoxicity |
| 71 | 4 | 0.04 | effect of hardness on tablet parameters |
| 72 | 4 | 0.04 | weight variation calculation of tablet p... |
| 73 | 4 | 0.04 | c2c8b67e9733d7c3b25c9249cd460941 |
| 74 | 4 | 0.04 | detection of bpa in water |
| 75 | 4 | 0.04 | sodium alginate beads pdf |
| 76 | 4 | 0.04 | role of pharmacist in community healthca... |
| 77 | 4 | 0.04 | fomulation and evaluation of microsphere... |
| 78 | 4 | 0.04 | stability indicating hplc method |
| 79 | 4 | 0.04 | tropical journal of pharmaceutical resea... |
| 80 | 4 | 0.04 | formulation pdf |
| 81 | 4 | 0.04 | conclusion of presentation of analgesic ... |
| 82 | 4 | 0.04 | http://www.tjpr.org/vol13_no1/2014_13_1_... |
| 83 | 4 | 0.04 | (Google Cache) |
| 84 | 4 | 0.04 | tropical journal of pharmaceutical resea... |
| 85 | 4 | 0.04 | pdf of nano drug delivery?q=pdf of nano ... |
| 86 | 4 | 0.04 | journal international antioxidant pandan... |
| 87 | 4 | 0.04 | for what is quercus infectoria? |
| 88 | 4 | 0.04 | tropical j of |
| 89 | 4 | 0.04 | screenin of antioxidant activity orf som... |
| 90 | 4 | 0.04 | penetration enhancer |
| 91 | 4 | 0.04 | http://www.tjpr.org/vol13_no2/2014_13_2_... |
| 92 | 4 | 0.04 | oral film technology b.pharma project?q=... |
| 93 | 4 | 0.04 | ethnobotany pdf |
| 94 | 4 | 0.04 | paper presentation on mouth dissolving t... |
| 95 | 4 | 0.04 | oral microspheres by solvent evaporation... |
| 96 | 4 | 0.04 | process validation protocol pdf |
| 97 | 4 | 0.04 | phytochemical screening |
| 98 | 3 | 0.03 | nigerian medicinal plants used in the ma... |
| 99 | 3 | 0.03 | studies on wound healing properties |
| 100 | 3 | 0.03 | http://www.tjpr.org/vol8_no2/2009_8_2_9_... |
| 101 | 3 | 0.03 | antibacterial screening on plants agains... |
| 102 | 3 | 0.03 | vero cells in toxicity testing in medici... |
| 103 | 3 | 0.03 | l-asparaginase thesis |
| 104 | 3 | 0.03 | http://www.tjpr.org/vol8_no4/2009_8_4_6_... |
| 105 | 3 | 0.03 | review on oral tablets |
| 106 | 3 | 0.03 | phytochemical screening of medicinal pla... |
| 107 | 3 | 0.03 | structures of advanced techniques on tra... |
| 108 | 3 | 0.03 | techniques of beads coating pdf |
| 109 | 3 | 0.03 | studies related to assessment of knowled... |
| 110 | 3 | 0.03 | c3 c4 levels lupus |
| 111 | 3 | 0.03 | rate of abuse ibuprofen in saudi arabia |
| 112 | 3 | 0.03 | validation in pharmacy.pdf |
| 113 | 3 | 0.03 | oraly disintegrating tablet |
| 114 | 3 | 0.03 | http://www.tjpr.org/vol8_no1/2009_8_1_12... |
| 115 | 3 | 0.03 | filetype:pdf alpha glucisidase activity ... |
| 116 | 3 | 0.03 | www.tropical journal of pharmaceutical r... |
| 117 | 3 | 0.03 | skin permeability enhancer |
| 118 | 3 | 0.03 | international streptomyces project file ... |
| 119 | 3 | 0.03 | international guideline hypertension |
| 120 | 3 | 0.03 | ppt on nano enabled drug delivery |
| 121 | 3 | 0.03 | nutritional composition of stevia rebaud... |
| 122 | 3 | 0.03 | journal formulation of tablet exctract b... |
| 123 | 3 | 0.03 | complement c4 serum high |
| 124 | 3 | 0.03 | stevia |
| 125 | 3 | 0.03 | challenge faced when preparing herbal me... |
| 126 | 3 | 0.03 | http://www.tjpr.org/vol13_no2/2014_13_2_... |
| 127 | 3 | 0.03 | lupus c3 c4 |
| 128 | 3 | 0.03 | tropical journal of pharmaceutical resea... |
| 129 | 3 | 0.03 | boerhhavia diffusa?q=boerhhavia diffusa |
| 130 | 3 | 0.03 | ticagrelor hplc |
| 131 | 3 | 0.03 | usp monograph lumefantrine |
| 132 | 3 | 0.03 | alstonia boonei |
| 133 | 3 | 0.03 | http://tjpr.org/ |
| 134 | 3 | 0.03 | filetype:pdf yoruba, botanical and commo... |
| 135 | 3 | 0.03 | http://www.tjpr.org/instructions.php |
| 136 | 3 | 0.03 | community pharmacy practice in nigeria |
| 137 | 3 | 0.03 | toothpaste pdf |
| 138 | 3 | 0.03 | biodegradable nps |
| 139 | 3 | 0.03 | why solvent used in film coating |
| 140 | 3 | 0.03 | complience to jnc 7 |
| 141 | 3 | 0.03 | diabetes patient education, nigeria,pdf |
| 142 | 3 | 0.03 | validation of different process in pharm... |
| 143 | 3 | 0.03 | anticancer research pdf |
| 144 | 3 | 0.03 | carissa carandis research |
| 145 | 3 | 0.03 | optimization of diclofenac orodispersibl... |
| 146 | 3 | 0.03 | metformin hydrochloride containing float... |
| 147 | 3 | 0.03 | hipolipidemia treatment plants |
| 148 | 3 | 0.03 | antimicrobial potential of extracts from... |
| 149 | 3 | 0.03 | http://www.tjpr.org |
| 150 | 3 | 0.03 | anti diarrhoeal stydy on rats |
| 151 | 3 | 0.03 | nanotechnology on drugs synethsis |
| 152 | 3 | 0.03 | drug penetration to skin |
| 153 | 3 | 0.03 | chemical constituents of mimusops elenji |
| 154 | 3 | 0.03 | http://www.tjpr.org/vol8_no3/2009_8_3_12... |
| 155 | 3 | 0.03 | 20 |
| 156 | 3 | 0.03 | eudragit rs 100 as a sustained release p... |
| 157 | 3 | 0.03 | assessment of microbial load in milk |
| 158 | 3 | 0.03 | penetration enhancers transdermal |
| 159 | 3 | 0.03 | sennosides laxative |
| 160 | 3 | 0.03 | hypertension guidelines adherence in nig... |
| 161 | 3 | 0.03 | http://www.tjpr.org/vol13_no2/2014_13_2_... |
| 162 | 3 | 0.03 | metformin hydrochloride gels |
| 163 | 3 | 0.03 | what is validation in pharma |
| 164 | 3 | 0.03 | anti-cancer filetype:pdf |
| 165 | 3 | 0.03 | tropical jhournal of pharmacetical resea... |
| 166 | 3 | 0.03 | pdf on controlled drug delivery system |
| 167 | 3 | 0.03 | anticonvulsant activity |
| 168 | 3 | 0.03 | http://www.tjpr.org/vol8_no2/2009_8_2_11... |
| 169 | 3 | 0.03 | objectives of multiparticulate |
| 170 | 3 | 0.03 | suppositories formulation |
| 171 | 3 | 0.03 | journal of "antimicrobial agents" |
| 172 | 3 | 0.03 | serum c4 prevention |
| 173 | 3 | 0.03 | review articles on oral disintegrating f... |
| 174 | 3 | 0.03 | male dispencor in pakistan |
| 175 | 3 | 0.03 | home management of malaria: the role of ... |
| 176 | 3 | 0.03 | nano drug delivery pdf |
| 177 | 2 | 0.02 | spourmohammad@qums.ac.ir loc:us |
| 178 | 2 | 0.02 | prescription pattern of antihypertensive... |
| 179 | 2 | 0.02 | management of co-morbidity of hypertenti... |
| 180 | 2 | 0.02 | defination process validation in parma p... |
| 181 | 2 | 0.02 | corydalis bungeana |
| 182 | 2 | 0.02 | assay of chloroquine phosphate by non aq... |
| 183 | 2 | 0.02 | furosemide pdf |
| 184 | 2 | 0.02 | transdermal drug delivery system pdf |
| 185 | 2 | 0.02 | manegment of anti hypertension in pharma |
| 186 | 2 | 0.02 | tropical journal of pharmaceutical scien... |
| 187 | 2 | 0.02 | trans dermal drug delivry system |
| 188 | 2 | 0.02 | penetration enhancer review pdf |
| 189 | 2 | 0.02 | nanotechnology of cosmetis and drug deli... |
| 190 | 2 | 0.02 | most common nigerian snake from jos |
| 191 | 2 | 0.02 | is there any way to increase complement ... |
| 192 | 2 | 0.02 | irrational use of drugs among uniuyo stu... |
| 193 | 2 | 0.02 | floating microspheres used in the treatm... |
| 194 | 2 | 0.02 | water uptake limit tablet |
| 195 | 2 | 0.02 | pdf file suppostries |
| 196 | 2 | 0.02 | http://www.tjpr.org/vol13_no2/2014_13_2_... |
| 197 | 2 | 0.02 | why stability indicating method |
| 198 | 2 | 0.02 | serum compliment level |
| 199 | 2 | 0.02 | pharmacognostic evaluation of fungi on c... |
| 200 | 2 | 0.02 | jazzimian@qums.ac.ir loc:us |
| 201 | 2 | 0.02 | formulation and evaluation of controlled... |
| 202 | 2 | 0.02 | anti inflammatory of byrsocarpus coccine... |
| 203 | 2 | 0.02 | ranolazine stability indicating by hplc |
| 204 | 2 | 0.02 | mchuta@mfu.ac.th loc:us |
| 205 | 2 | 0.02 | http://www.tjpr.org/vol13_no2/2014_13_2_... |
| 206 | 2 | 0.02 | hygrophila auriculata pdf download |
| 207 | 2 | 0.02 | ipqa basics in pharma |
| 208 | 2 | 0.02 | synthesis of pleurotus tuberegium |
| 209 | 2 | 0.02 | dsc of theophylline drug |
| 210 | 2 | 0.02 | what is staphylococcus aureus isolated i... |
| 211 | 2 | 0.02 | oro dispersible tablets |
| 212 | 2 | 0.02 | high c3 component levels |
| 213 | 2 | 0.02 | validation of pharmaceutical processes |
| 214 | 2 | 0.02 | munavvar abdul sattar |
| 215 | 2 | 0.02 | http://www.tjpr.org/vol13_no1/2014_13_1_... |
| 216 | 2 | 0.02 | bitter kola as an antimicrobail agent |
| 217 | 2 | 0.02 | assessment of pharmaceutical care in ... |
| 218 | 2 | 0.02 | is there any occurence of rattle snake b... |
| 219 | 2 | 0.02 | elevates c3 lvels ana |
| 220 | 2 | 0.02 | effects of plant extract on liver protei... |
| 221 | 2 | 0.02 | current pharma res |
| 222 | 2 | 0.02 | tropical journal of |
| 223 | 2 | 0.02 | pharmaceutical process validation report... |
| 224 | 2 | 0.02 | polysaccharide used for gastroretention |
| 225 | 2 | 0.02 | microspheres formulation?q=microspheres ... |
| 226 | 2 | 0.02 | dregea volubilis uses |
| 227 | 2 | 0.02 | xuemei.liu@xibei.com.cn loc:us |
| 228 | 2 | 0.02 | http://www.tjpr.org/vol8_no2/2009_8_2_10... |
| 229 | 2 | 0.02 | decreased c3 and c4 serum complement |
| 230 | 2 | 0.02 | thesis paper on microsphere formulation... |
| 231 | 2 | 0.02 | pdf for anticonvelsent |
| 232 | 2 | 0.02 | nanotechnology in biomaterials pdf |
| 233 | 2 | 0.02 | microparticles research atticle pdf |
| 234 | 2 | 0.02 | tropical journal of pharmaceutical resea... |
| 235 | 2 | 0.02 | stevia rebaudiana |
| 236 | 2 | 0.02 | raidore plant medicinal |
| 237 | 2 | 0.02 | physical and chemical permeation enhance... |
| 238 | 2 | 0.02 | effect of herbal plant on healing of bu... |
| 239 | 2 | 0.02 | validation of pharma |
| 240 | 2 | 0.02 | nanotecthnology in drugs synethsis |
| 241 | 2 | 0.02 | procedure of isolation of reserpine |
| 242 | 2 | 0.02 | erigeron floribundus |
| 243 | 2 | 0.02 | difference between sennoside a and senno... |
| 244 | 2 | 0.02 | in vitro anticancer activity pdf |
| 245 | 2 | 0.02 | "gentamicin" filetype:pdf |
| 246 | 2 | 0.02 | journal of diuretic medicine.pdf |
| 247 | 2 | 0.02 | c3 and c4 levels |
| 248 | 2 | 0.02 | orally disintegrating tablets |
| 249 | 2 | 0.02 | evaluation of difference carbopol grades... |
| 250 | 2 | 0.02 | comparative evaluation of diuretic activ... |
| 251 | 2 | 0.02 | types of validation pdf |
| 252 | 2 | 0.02 | tropical j of tropical |
| 253 | 2 | 0.02 | home exirces -mon |
| 254 | 2 | 0.02 | taha naji jiangnan |
| 255 | 2 | 0.02 | http://www.tjpr.org/vol13_no1/2014_13_1_... |
| 256 | 2 | 0.02 | content |
| 257 | 2 | 0.02 | ulinastatin sap |
| 258 | 2 | 0.02 | tropical j of pharma resaerch |
| 259 | 2 | 0.02 | why is ftir used for microspheres |
| 260 | 2 | 0.02 | pharm res open access |
| 261 | 2 | 0.02 | nano drug delivery technology |
| 262 | 2 | 0.02 | complement c3 in pdf file |
| 263 | 2 | 0.02 | snakes of nigeria |
| 264 | 2 | 0.02 | research papers on drug distribution in ... |
| 265 | 2 | 0.02 | c3 levels use to diagnoses |
| 266 | 2 | 0.02 | s-c3/c4 |
| 267 | 2 | 0.02 | nanoparticles+elicitor |
| 268 | 2 | 0.02 | liposomes by ethanol injection diclofena... |
| 269 | 2 | 0.02 | famotidine tablet formulation |
| 270 | 2 | 0.02 | manual of ethanobotany pdf?q=manual of e... |
| 271 | 2 | 0.02 | glipizide eudragit microspheres |
| 272 | 2 | 0.02 | application of nano drug technology |
| 273 | 2 | 0.02 | antibiotics actinomycetes |
| 274 | 2 | 0.02 | 422715d42e094c71fbea567d75288446 |
| 275 | 2 | 0.02 | wheal of stratum corneum |
| 276 | 2 | 0.02 | losartan potassium chlorthalidone=uv an... |
| 277 | 2 | 0.02 | disadvantages of nanotechnology in drug ... |
| 278 | 2 | 0.02 | tropical journal of pharmaceutical reaea... |
| 279 | 2 | 0.02 | trjpr |
| 280 | 2 | 0.02 | stability indicating hplc method?q=stabi... |
| 281 | 2 | 0.02 | role of crp in atherosclerosis |
| 282 | 2 | 0.02 | hypocholesterolemic |
| 283 | 2 | 0.02 | analgesic effects |
| 284 | 2 | 0.02 | why nano drug delivery system is superio... |
| 285 | 2 | 0.02 | low complement glomerulonephritis causes... |
| 286 | 2 | 0.02 | http://www.tjpr.org/vol8_no1/2009_8_1_10... |
| 287 | 2 | 0.02 | stachys , stachys lavandulifolia , tissu... |
| 288 | 2 | 0.02 | formulation of orodispersible tablet res... |
| 289 | 2 | 0.02 | histology of terminalia glaucescens |
| 290 | 2 | 0.02 | foreign studies of wound healing |
| 291 | 2 | 0.02 | basic concept of development of pedriatr... |
| 292 | 2 | 0.02 | portulaca oleracea |
| 293 | 2 | 0.02 | penetration enhancers?q=penetration enha... |
| 294 | 2 | 0.02 | ethnobotany |
| 295 | 2 | 0.02 | ranolazine stability indicating method |
| 296 | 2 | 0.02 | process validation pharmacy |
| 297 | 2 | 0.02 | pharmaceutical validation |
| 298 | 2 | 0.02 | multiparticulate drug delivery system |
| 299 | 2 | 0.02 | list of comonly used antimalarial drug p... |
| 300 | 2 | 0.02 | drug delivery pdf download |
| 301 | 2 | 0.02 | active compd of alstonia boonei |
| 302 | 2 | 0.02 | simple phytochemical screening methods |
| 303 | 2 | 0.02 | phytochemical test |
| 304 | 2 | 0.02 | related articles of blumea balsamifera |
| 305 | 2 | 0.02 | ir of ciprofloxacin |
| 306 | 2 | 0.02 | drug delivery system capsule |
| 307 | 2 | 0.02 | alstonia boonei pdf |
| 308 | 2 | 0.02 | tablet formulation pdf |
| 309 | 2 | 0.02 | microsphere preparation pdf |
| 310 | 2 | 0.02 | litrature review on comparative analysis... |
| 311 | 2 | 0.02 | validation process in pharma?q=validatio... |
| 312 | 2 | 0.02 | the albinos rat pdf |
| 313 | 2 | 0.02 | how to calculate the concentration of me... |
| 314 | 2 | 0.02 | complement component c4c value 15 |
| 315 | 2 | 0.02 | permeation enhancers used in transdermal... |
| 316 | 2 | 0.02 | novel drug delivery system of nanotechno... |
| 317 | 2 | 0.02 | http://www.tjpr.org/vol8_no3/2009_8_3_11... |
| 318 | 2 | 0.02 | anticonvulsant effect of plant extracts ... |
| 319 | 2 | 0.02 | affican herbal medicine is not reliable |
| 320 | 2 | 0.02 | how to administer extract to rats orally |
| 321 | 2 | 0.02 | caliberation curve of meloxicam at 355 |
| 322 | 2 | 0.02 | how ethnobotany has contributed to devel... |
| 323 | 2 | 0.02 | dihydtoartmisinin u.v.absorption spectru... |
| 324 | 2 | 0.02 | areas of knowledge of malaria |
| 325 | 2 | 0.02 | theophylline er tablet abstract |
| 326 | 2 | 0.02 | any,contains,health benefits of tea |
| 327 | 2 | 0.02 | tween 80 in suppository |
| 328 | 2 | 0.02 | silymarin drug patent |
| 329 | 2 | 0.02 | http://www.tjpr.org/jmanager/manuscript/... |
| 330 | 2 | 0.02 | http://www.tjpr.org/vol13_no2/2014_13_2_... |
| 331 | 2 | 0.02 | validation meaning in pharma |
| 332 | 2 | 0.02 | herbaceous plant used in curing toxicity... |
| 333 | 2 | 0.02 | suppositories pdf |
| 334 | 2 | 0.02 | strenth of artesunate |
| 335 | 2 | 0.02 | orodispersible tablets |
| 336 | 2 | 0.02 | drug delivery system nanotechnology |
| 337 | 2 | 0.02 | c3 and c4 |
| 338 | 2 | 0.02 | antiprotozoal raimondia cf. monoica carm... |
| 339 | 2 | 0.02 | what are the advantages and disadvantage... |
| 340 | 2 | 0.02 | medicine harmon genret tablet and syrup |
| 341 | 2 | 0.02 | http://www.tjpr.org/vol13_no1/2014_13_1_... |
| 342 | 2 | 0.02 | ana test pediatric 1:320 sle c4 compleme... |
| 343 | 2 | 0.02 | aleo schwenfurthi pdf |
| 344 | 2 | 0.02 | published papers on anticonvulsant activ... |
| 345 | 2 | 0.02 | pharmaceutical validation pdf |
| 346 | 2 | 0.02 | steps in drug validation |
| 347 | 2 | 0.02 | factors that affect drug dispensing |
| 348 | 2 | 0.02 | [pdf] salbutamol + theophyline |
| 349 | 2 | 0.02 | methods of antibiotic producing actinomy... |
| 350 | 2 | 0.02 | http://www.tjpr.org/vol13_no2/2014_13_2_... |
| 351 | 2 | 0.02 | 8dc6169a075cc2dfd34e39dab39a6c54 |
| 352 | 2 | 0.02 | egamero@medicus.com.mx loc:us |
| 353 | 2 | 0.02 | sample size estimation araoye et al |
| 354 | 2 | 0.02 | multiparticulate formulation |
| 355 | 2 | 0.02 | lambda max of bsa nanoparticles |
| 356 | 2 | 0.02 | ipqa test of pharma pdf?q=ipqa test of p... |
| 357 | 2 | 0.02 | low c4 normal c3 |
| 358 | 2 | 0.02 | carbapol 50 mg |
| 359 | 2 | 0.02 | tropical journal of pharmaceutical reser... |
| 360 | 2 | 0.02 | nanotechnology part pdf |
| 361 | 2 | 0.02 | majuphal for operation wound |
| 362 | 2 | 0.02 | management of snake bite in nigeria |
| 363 | 2 | 0.02 | www.validation. in pharmaceutical |
| 364 | 2 | 0.02 | mucin pdf?q=mucin pdf |
| 365 | 2 | 0.02 | floating microspheres for h.pylori |
| 366 | 2 | 0.02 | define validation in pharma |
| 367 | 2 | 0.02 | cache:http://www.tjpr.org/vol13_no1/inde... |
| 368 | 2 | 0.02 | research project on gas chromatography o... |
| 369 | 2 | 0.02 | phytochemical screening for carissa cong... |
| 370 | 2 | 0.02 | importing pharmacy into nigeria |
| 371 | 2 | 0.02 | high c4 normal c3 |
| 372 | 2 | 0.02 | shabotorabi@qums.ac.ir loc:us |
| 373 | 2 | 0.02 | new anti convulsent activty pdf |
| 374 | 2 | 0.02 | huangguidong,2013 |
| 375 | 2 | 0.02 | guidelines for validation in pharma pdf |
| 376 | 2 | 0.02 | fast red dye and artesunate |
| 377 | 2 | 0.02 | slmp@slmp.org.pk loc:us |
| 378 | 2 | 0.02 | pharmacological models for anticonvulsan... |
| 379 | 2 | 0.02 | nageen hussain dnase 1 gene |
| 380 | 2 | 0.02 | how to calculate tablet formula |
| 381 | 2 | 0.02 | extract prostate cancer |
| 382 | 2 | 0.02 | validation in pharmacy |
| 383 | 2 | 0.02 | product validation in pharma?q=product v... |
| 384 | 2 | 0.02 | permation enhancers |
| 385 | 2 | 0.02 | micelle preparation |
| 386 | 2 | 0.02 | how ethnobotany has led to development o... |
| 387 | 2 | 0.02 | tropical journal of pharmacy research |
| 388 | 2 | 0.02 | role of ethnobotany in development of mo... |
| 389 | 2 | 0.02 | http://www.tjpr.org/vol13_no2/2014_13_2_... |
| 390 | 2 | 0.02 | formulation tablets pdf |
| 391 | 2 | 0.02 | eudragit microsphere pdf |
| 392 | 2 | 0.02 | hadge anticonvulsan activity of |
| 393 | 2 | 0.02 | dose of diazepam for mice |
| 394 | 2 | 0.02 | boerhaavia diffusa pdf form |
| 395 | 2 | 0.02 | abstract on determination of microbial q... |
| 396 | 2 | 0.02 | a.k. mishra, a. misra, p. chattopadhyay,... |
| 397 | 2 | 0.02 | pharmaceutical quality control a review ... |
| 398 | 2 | 0.02 | metronidazole pdf download |
| 399 | 2 | 0.02 | methods to prepare microsphere |
| 400 | 2 | 0.02 | prof magnus iwuagwu's work on disintegra... |
| 401 | 2 | 0.02 | c3 serum |
| 402 | 2 | 0.02 | anti convulsant effect of plant extract |
| 403 | 2 | 0.02 | validation in pharmaceuticals |
| 404 | 1 | 0.01 | water contamination in benin |
| 405 | 1 | 0.01 | title-abs-key(chitosan) |
| 406 | 1 | 0.01 | reasons for low c3 and c4 |
| 407 | 1 | 0.01 | ticagrelor hplc method |
| 408 | 1 | 0.01 | prepare the toothpaste pdf |
| 409 | 1 | 0.01 | powdered soya milk processing industries... |
| 410 | 1 | 0.01 | present available 5-flurouracil or in co... |
| 411 | 1 | 0.01 | complement c3 serum low |
| 412 | 1 | 0.01 | antihypertensive plant extract |
| 413 | 1 | 0.01 | a method for the prediction of in vivo b... |
| 414 | 1 | 0.01 | article of drug delivery by nano capsule... |
| 415 | 1 | 0.01 | effect of aqueous extract on ast level |
| 416 | 1 | 0.01 | formula of calcium sennosides pdf |
| 417 | 1 | 0.01 | malaria life cycle of plasmodium |
| 418 | 1 | 0.01 | low c3 levels |
| 419 | 1 | 0.01 | dsc cyclidextrin simvastatin |
| 420 | 1 | 0.01 | progress in controlled gastroretentive d... |
| 421 | 1 | 0.01 | http://www.tjpr.org/vol7_no1/713behera.p... |
| 422 | 1 | 0.01 | pharmaceutical formulations included wit... |
| 423 | 1 | 0.01 | sle diagnostic criteria complement |
| 424 | 1 | 0.01 | zam nworgu et al |
| 425 | 1 | 0.01 | springer journals pharmacy with no publi... |
| 426 | 1 | 0.01 | snakes in nigeria |
| 427 | 1 | 0.01 | pdf piper crocatum antibacterial antimic... |
| 428 | 1 | 0.01 | microbiological analysis of milk samples |
| 429 | 1 | 0.01 | role of pharmacists in primary health c... |
| 430 | 1 | 0.01 | diclofenac oral dispersible tablet fact... |
| 431 | 1 | 0.01 | "hunteria zeylanica" tradisional use |
| 432 | 1 | 0.01 | preparation of theophylline microspheres... |
| 433 | 1 | 0.01 | int j res ayurved pharm |
| 434 | 1 | 0.01 | importance of c3, c4 level in renal dise... |
| 435 | 1 | 0.01 | c3 c4 kryoglobulinemia proteinuria |
| 436 | 1 | 0.01 | thionin nissl body staining methods rat ... |
| 437 | 1 | 0.01 | boerhevia diffusa side effects |
| 438 | 1 | 0.01 | maisa abu kamar |
| 439 | 1 | 0.01 | lupus c4 levels |
| 440 | 1 | 0.01 | pharmacokinetic parameters, determined b... |
| 441 | 1 | 0.01 | research articles on matrix tablets eval... |
| 442 | 1 | 0.01 | sustainable development of chemistry |
| 443 | 1 | 0.01 | the methods of identification ecdysteroi... |
| 444 | 1 | 0.01 | http://www.tjpr.org/vol3_no1/33oreagba.p... |
| 445 | 1 | 0.01 | how can resistant brucella be treated |
| 446 | 1 | 0.01 | clindamycin susceptibility to s.aureus ... |
| 447 | 1 | 0.01 | c4 complement 35 |
| 448 | 1 | 0.01 | different department in national institu... |
| 449 | 1 | 0.01 | saurabh bareily pharmacy faculty |
| 450 | 1 | 0.01 | temperature of media in disintegration t... |
| 451 | 1 | 0.01 | understanding pharmaceutical validation |
| 452 | 1 | 0.01 | artemether lumefantrine/validation data |
| 453 | 1 | 0.01 | 1050312986@erciyes.edu.tr loc:us |
| 454 | 1 | 0.01 | invitro anti tubercular screening |
| 455 | 1 | 0.01 | what is multiparticulate system |
| 456 | 1 | 0.01 | antimicrobial effects of indian medicina... |
| 457 | 1 | 0.01 | african violets journalseek |
| 458 | 1 | 0.01 | cream containing extract of plant naveed... |
| 459 | 1 | 0.01 | http://www.tjpr.org/vol11_no5/2012_11_5_... |
| 460 | 1 | 0.01 | crushing strength-friability ratio |
| 461 | 1 | 0.01 | boerhavia diffusa pdf |
| 462 | 1 | 0.01 | advantages of multi particulate system f... |
| 463 | 1 | 0.01 | active compd of alstonia boonei pdf |
| 464 | 1 | 0.01 | use of crissa carandas pdf file |
| 465 | 1 | 0.01 | validation in pharma in detailes |
| 466 | 1 | 0.01 | what are the constituents are separated ... |
| 467 | 1 | 0.01 | pdf transdermal drug delivery system |
| 468 | 1 | 0.01 | medicinal uses of dregea volubilis benth... |
| 469 | 1 | 0.01 | minimum dose for oral disintegrating tab... |
| 470 | 1 | 0.01 | reaserch articles for floating beads |
| 471 | 1 | 0.01 | pharmacists least involved in primary pr... |
| 472 | 1 | 0.01 | review article on pharmaceutical analyti... |
| 473 | 1 | 0.01 | skin treatment by transdermal drug deliv... |
| 474 | 1 | 0.01 | how to obtain tagushi design software in... |
| 475 | 1 | 0.01 | current journal of pharmaceutical resear... |
| 476 | 1 | 0.01 | hunteria umbellata |
| 477 | 1 | 0.01 | review articles on pharmaceutical table... |
| 478 | 1 | 0.01 | clitoria ternatea blood |
| 479 | 1 | 0.01 | c3 nephropathy |
| 480 | 1 | 0.01 | colorimetric determination of ceftriaxon... |
| 481 | 1 | 0.01 | review articles on validation of drug pd... |
| 482 | 1 | 0.01 | research paper on antimicrobial activit... |
| 483 | 1 | 0.01 | nanotechnology: what it can do for drug ... |
| 484 | 1 | 0.01 | mitic@mojakola.net loc:us |
| 485 | 1 | 0.01 | odt 30 seconds saliva |
| 486 | 1 | 0.01 | what is pharma validation |
| 487 | 1 | 0.01 | skwakye93@yahoo.com |
| 488 | 1 | 0.01 | alstonia,pdf |
| 489 | 1 | 0.01 | how long is complement c3 and c4 |
| 490 | 1 | 0.01 | choice of excipients and formulation of ... |
| 491 | 1 | 0.01 | trop j pharm res, |
| 492 | 1 | 0.01 | sustainable development and green chemis... |
| 493 | 1 | 0.01 | role of c3 and c4 in body |
| 494 | 1 | 0.01 | serum c3 is persistently low |
| 495 | 1 | 0.01 | snakes in western nigeria |
| 496 | 1 | 0.01 | in process testing pharmaceutical |
| 497 | 1 | 0.01 | http://www.tjpr.org/vol12_no5/2013_12_5_... |
| 498 | 1 | 0.01 | fast dissolving tablets review article p... |
| 499 | 1 | 0.01 | drugs in form of bead |
| 500 | 1 | 0.01 | filetype:pdf homoeopathy brasil experime... |
| 501 | 1 | 0.01 | pharmaceutical journals |
| 502 | 1 | 0.01 | interactin between peniccilum and staphy... |
| 503 | 1 | 0.01 | phytochemical and antioxidant activities... |
| 504 | 1 | 0.01 | phytochemical and antioxidant activities... |
| 505 | 1 | 0.01 | marwa jamshaid khan |
| 506 | 1 | 0.01 | macdonald idu, university of benin |
| 507 | 1 | 0.01 | equations for assay of chloroquine phosp... |
| 508 | 1 | 0.01 | customer satisfaction community pharmacy... |
| 509 | 1 | 0.01 | drug dissolution test of suppositories |
| 510 | 1 | 0.01 | gentamicin induced nephrotoxicity in rat... |
| 511 | 1 | 0.01 | kmwambete@muhas.ac.tz |
| 512 | 1 | 0.01 | adabestan@iauh.ac.ir loc:us |
| 513 | 1 | 0.01 | why check c3 c4 levels |
| 514 | 1 | 0.01 | those that have used a boonei as plant e... |
| 515 | 1 | 0.01 | swinyard ea. laboratory evaluation of an... |
| 516 | 1 | 0.01 | chitosan dsc |
| 517 | 1 | 0.01 | antitumor plant extracts |
| 518 | 1 | 0.01 | brassicaceae lepidium sativum |
| 519 | 1 | 0.01 | http://www.tjpr.org/vol13_no1/2014_13_1_... |
| 520 | 1 | 0.01 | olilafrancis |
| 521 | 1 | 0.01 | mouth dissolving tablet of 60mg drug in... |
| 522 | 1 | 0.01 | flavanone |
| 523 | 1 | 0.01 | low c4 levels in lupus |
| 524 | 1 | 0.01 | clavenger apparatus in nigeria |
| 525 | 1 | 0.01 | a. buettneri |
| 526 | 1 | 0.01 | ageratum conyzoides toxicity |
| 527 | 1 | 0.01 | depression of complement levels in the b... |
| 528 | 1 | 0.01 | firmulation and evaluation of salbutamo... |
| 529 | 1 | 0.01 | s. honary*, k. ghajar, p. khazaeli and p... |
| 530 | 1 | 0.01 | professor patrick erah |
| 531 | 1 | 0.01 | review of literature of oral disintegrat... |
| 532 | 1 | 0.01 | paracetamol induced in vivo hepatotoxici... |
| 533 | 1 | 0.01 | tropical journal of pharm |
| 534 | 1 | 0.01 | sesamin agonist of ppar gamma |
| 535 | 1 | 0.01 | test methods of phellandrene by gas chro... |
| 536 | 1 | 0.01 | universities with pharmaceutical technol... |
| 537 | 1 | 0.01 | validation of drugs |
| 538 | 1 | 0.01 | phyto chemical screening ofsuaeda nudifl... |
| 539 | 1 | 0.01 | medicinal plants used in wound healing ... |
| 540 | 1 | 0.01 | marine pharmacognosy abstract |
| 541 | 1 | 0.01 | najafi@iauh.ac.ir |
| 542 | 1 | 0.01 | adherence to international and national ... |
| 543 | 1 | 0.01 | hod pharmacy department psychiatric hosp... |
| 544 | 1 | 0.01 | ideal pharmacokinetic ranges for oral di... |
| 545 | 1 | 0.01 | complement c3 bl |
| 546 | 1 | 0.01 | c3h hepg2 |
| 547 | 1 | 0.01 | asteraceae pdf |
| 548 | 1 | 0.01 | a pdf file on stevia |
| 549 | 1 | 0.01 | brine shrimp research articles |
| 550 | 1 | 0.01 | formulation and evaluation of theophylli... |
| 551 | 1 | 0.01 | conventional tablets reviews |
| 552 | 1 | 0.01 | isolation and identification of pathogen... |
| 553 | 1 | 0.01 | 30. s. honary*, k. ghajar, p. khazaeli a... |
| 554 | 1 | 0.01 | steps in production of pharmaceutical d... |
| 555 | 1 | 0.01 | types of validation in pharmacy |
| 556 | 1 | 0.01 | propolis and alpha glucosidase, alpha a... |
| 557 | 1 | 0.01 | pharmaceutical research, words of abstra... |
| 558 | 1 | 0.01 | review of literature on clitoria ternate... |
| 559 | 1 | 0.01 | effect of leaf alkaloids on the serum l... |
| 560 | 1 | 0.01 | double emulsion method for microsphere |
| 561 | 1 | 0.01 | physical properties of artesunate table... |
| 562 | 1 | 0.01 | which disntirigated material very fast d... |
| 563 | 1 | 0.01 | c3 & c4 in relation to lupus |
| 564 | 1 | 0.01 | kpr emulsion |
| 565 | 1 | 0.01 | formulation and evaluation of orodispers... |
| 566 | 1 | 0.01 | international journal of pharmaceutical ... |
| 567 | 1 | 0.01 | mosmann anticancerous 1983 |
| 568 | 1 | 0.01 | permeability enhancement + bcs filetype:... |
| 569 | 1 | 0.01 | nanotechnology in drug delivery pdf |
| 570 | 1 | 0.01 | http://www.tjpr.org/vol13_no2/2014_13_2_... |
| 571 | 1 | 0.01 | glipizide microspheres |
| 572 | 1 | 0.01 | bioequivalence of metronidazole pdf |
| 573 | 1 | 0.01 | anti-inflammatory effects of magnolia si... |
| 574 | 1 | 0.01 | best spot transdermal. drug absorbed |
| 575 | 1 | 0.01 | fig protein expression of ldlr hmgr c... |
| 576 | 1 | 0.01 | dendrimers novel drug delivery system re... |
| 577 | 1 | 0.01 | formulatio and evalution of orodispersib... |
| 578 | 1 | 0.01 | the rats in the control group only open ... |
| 579 | 1 | 0.01 | screening of phytochemicals lactose pdf |
| 580 | 1 | 0.01 | pdf and ppt on release of drug mechanism... |
| 581 | 1 | 0.01 | raised c3and c4 |
| 582 | 1 | 0.01 | using breadfruit for leukemia |
| 583 | 1 | 0.01 | a benesi hildebrand equation |
| 584 | 1 | 0.01 | antipyretic property of plants pdf |
| 585 | 1 | 0.01 | thammarat@mbu.ac.th loc:us |
| 586 | 1 | 0.01 | standard proposal for ethnobotanical re... |
| 587 | 1 | 0.01 | pharmaceutical journals in south africa |
| 588 | 1 | 0.01 | proteinuria and low c4 |
| 589 | 1 | 0.01 | raymond ozolua |
| 590 | 1 | 0.01 | hypoglycemic effect of the aqueous extra... |
| 591 | 1 | 0.01 | how biotechnology is involved in milk qu... |
| 592 | 1 | 0.01 | http://www.tjpr.org gmp |
| 593 | 1 | 0.01 | methyl jasmonic acid marigold |
| 594 | 1 | 0.01 | lupus complement levels |
| 595 | 1 | 0.01 | microbial contamination of oral dosage |
| 596 | 1 | 0.01 | nanoemulsion2013 |
| 597 | 1 | 0.01 | transdermal drug delivery, pdf |
| 598 | 1 | 0.01 | tablet preparation by using mannitol |
| 599 | 1 | 0.01 | stevia 2014 |
| 600 | 1 | 0.01 | the fundamental principle of process val... |
| 601 | 1 | 0.01 | penetration enhancer |
| 602 | 1 | 0.01 | oral disintegrating tablet reference pro... |
| 603 | 1 | 0.01 | oral drug delivery system |
| 604 | 1 | 0.01 | quercus infectoria |
| 605 | 1 | 0.01 | solid lipid nanoparticles review |
| 606 | 1 | 0.01 | artesunate tablets |
| 607 | 1 | 0.01 | nebivolol and osteopenia |
| 608 | 1 | 0.01 | uses of arthocleista nobilis and chroyso... |
| 609 | 1 | 0.01 | tropical journal of pharmastical researc... |
| 610 | 1 | 0.01 | z2hq07@scut.edu.cn loc:us |
| 611 | 1 | 0.01 | complement c3 c4 |
| 612 | 1 | 0.01 | buccal tablets review arti |
| 613 | 1 | 0.01 | drug designing in nanotechnology definit... |
| 614 | 1 | 0.01 | anti-inflammatory effects of magnolia si... |
| 615 | 1 | 0.01 | validation pharma?q=validation pharma |
| 616 | 1 | 0.01 | 2%,5%,10% concentration of leaf extract |
| 617 | 1 | 0.01 | statistical calculations for hplc pdf |
| 618 | 1 | 0.01 | occurance of microbial contamination in ... |
| 619 | 1 | 0.01 | taruna katyal |
| 620 | 1 | 0.01 | use of oral disintegrating tablets |
| 621 | 1 | 0.01 | ghadir@qums.ac.ir loc:us |
| 622 | 1 | 0.01 | floating multiparticulate drug delivery |
| 623 | 1 | 0.01 | gastroretentive drug delivery system pdf |
| 624 | 1 | 0.01 | calculation of diuretic index |
| 625 | 1 | 0.01 | home management of uncomplicated malaria... |
| 626 | 1 | 0.01 | how can we prevent low levels of c3 and ... |
| 627 | 1 | 0.01 | malaria in children in nigeria |
| 628 | 1 | 0.01 | ionic liquids in drug discovery |
| 629 | 1 | 0.01 | igbikstamuno |
| 630 | 1 | 0.01 | epilepsy induced methods articles in ani... |
| 631 | 1 | 0.01 | http://www.tjpr.org/vol7_no2/722adisa.pd... |
| 632 | 1 | 0.01 | aqueous herbal extract pdf |
| 633 | 1 | 0.01 | c4 in sle |
| 634 | 1 | 0.01 | effervescent gastroretentive system- a r... |
| 635 | 1 | 0.01 | tropical journal of pharmaceutical |
| 636 | 1 | 0.01 | sorption promoters |
| 637 | 1 | 0.01 | tropical journal of pharma research |
| 638 | 1 | 0.01 | impact factor+tropical journal of pharma... |
| 639 | 1 | 0.01 | organophosphorus poisoning |
| 640 | 1 | 0.01 | orally disintegrating tablets ph |
| 641 | 1 | 0.01 | method involved in validation equipment |
| 642 | 1 | 0.01 | normal range complement c3 and c4 |
| 643 | 1 | 0.01 | formulation and evaluation of michrosphe... |
| 644 | 1 | 0.01 | drug release effect of coating |
| 645 | 1 | 0.01 | filetype:pdf a sensitive and reliable lo... |
| 646 | 1 | 0.01 | in process control for pharmaceuticals p... |
| 647 | 1 | 0.01 | lupus nephritis serum complement |
| 648 | 1 | 0.01 | why do we check serum c3 c4 |
| 649 | 1 | 0.01 | tropical journal of pharmaceutical scien... |
| 650 | 1 | 0.01 | biopharmaceutical process development an... |
| 651 | 1 | 0.01 | decitabine for injection hplc method dev... |
| 652 | 1 | 0.01 | decreased c3 c4 levels |
| 653 | 1 | 0.01 | . s madan antimicrobial activity against... |
| 654 | 1 | 0.01 | what is cd4 percentage of lymphocytes if... |
| 655 | 1 | 0.01 | role of caregivers in mortality reductio... |
| 656 | 1 | 0.01 | serum complement c3 and c4 levels in rel... |
| 657 | 1 | 0.01 | antibiotic susceptibility pattern of sta... |
| 658 | 1 | 0.01 | 99350103 |
| 659 | 1 | 0.01 | challenges associated with malaria vacci... |
| 660 | 1 | 0.01 | review articles on nanotechnology pdf |
| 661 | 1 | 0.01 | http: http://www.tjpr.org/vol8_no2/2009_... |
| 662 | 1 | 0.01 | example of penetration enhancers for tra... |
| 663 | 1 | 0.01 | acanthaceae family pdf |
| 664 | 1 | 0.01 | drug delivery technology+2003+3+1 |
| 665 | 1 | 0.01 | n-acetylanonaine, antioxidant |
| 666 | 1 | 0.01 | indonesian herbal cure cancer pdf |
| 667 | 1 | 0.01 | normal complement c3 and low complement ... |
| 668 | 1 | 0.01 | papers from international journal of pha... |
| 669 | 1 | 0.01 | staphylococcus aureus against lemon gras... |
| 670 | 1 | 0.01 | solubility of ciprofloxacin |
| 671 | 1 | 0.01 | ohwoavworhua f.o, adelakun t.a. some phy... |
| 672 | 1 | 0.01 | nutritional composition of stevia rebaud... |
| 673 | 1 | 0.01 | pdf about natural home medicines |
| 674 | 1 | 0.01 | green chemistry advanced progress |
| 675 | 1 | 0.01 | http://www.tjpr.org/vol8_no3/2009_8_3_10... |
| 676 | 1 | 0.01 | paracetamol displacement value in theobr... |
| 677 | 1 | 0.01 | physicochemical properties of albizia gu... |
| 678 | 1 | 0.01 | flavanone nmr spectra |
| 679 | 1 | 0.01 | disintegation time limit for orodispersi... |
| 680 | 1 | 0.01 | kwoledge and practices among caregivers ... |
| 681 | 1 | 0.01 | analgesic activity tail immersion |
| 682 | 1 | 0.01 | antimicrobial activities of thespesia po... |
| 683 | 1 | 0.01 | low c4 serum |
| 684 | 1 | 0.01 | indian journal of traditional knowledge,... |
| 685 | 1 | 0.01 | biopharmaceutical classification system ... |
| 686 | 1 | 0.01 | african journal of pharmaceutical scienc... |
| 687 | 1 | 0.01 | antibacterial activity of isoniazid drug |
| 688 | 1 | 0.01 | complement c3 serum |
| 689 | 1 | 0.01 | effects of plant extract on albino rat ... |
| 690 | 1 | 0.01 | serum complement studies |
| 691 | 1 | 0.01 | qmsd@qums.ac.ir loc:us |
| 692 | 1 | 0.01 | microsphere formulation by solvent evapo... |
| 693 | 1 | 0.01 | pharmaceutical process qualification |
| 694 | 1 | 0.01 | sle c3/c4 |
| 695 | 1 | 0.01 | tablet formulation |
| 696 | 1 | 0.01 | transdermal penetration enhancers |
| 697 | 1 | 0.01 | tropical diseases affecting periodontium... |
| 698 | 1 | 0.01 | low c3 levels mean lupus |
| 699 | 1 | 0.01 | assessment knowledge about diabetes me... |
| 700 | 1 | 0.01 | what is validation in pharmacy |
| 701 | 1 | 0.01 | actinomycetes solid state culture |
| 702 | 1 | 0.01 | multiparticulate systems |
| 703 | 1 | 0.01 | metal chelating activity in mushrooms |
| 704 | 1 | 0.01 | pdf or journals: recent malaria vaccines |
| 705 | 1 | 0.01 | pharmacists role in a& e department |
| 706 | 1 | 0.01 | amperiadou, a., georgarakis, m., 1995. c... |
| 707 | 1 | 0.01 | tetrapleura tetraptera |
| 708 | 1 | 0.01 | http://www.tjpr.org |
| 709 | 1 | 0.01 | pharmaceutical validations |
| 710 | 1 | 0.01 | brand of drug that contain artesunate a... |
| 711 | 1 | 0.01 | drug delivery systems pdf |
| 712 | 1 | 0.01 | c4 protein of 17 |
| 713 | 1 | 0.01 | c3 complement level high |
| 714 | 1 | 0.01 | solution and identification of pathogeni... |
| 715 | 1 | 0.01 | antimicrobial evaluation of garcinia kol... |
| 716 | 1 | 0.01 | meaning of validation in pharmacy |
| 717 | 1 | 0.01 | formulation and evaluation of oral dispe... |
| 718 | 1 | 0.01 | http://www.tjpr.org/vol13_no2/2014_13_2_... |
| 719 | 1 | 0.01 | pandanus amaryllifolius |
| 720 | 1 | 0.01 | oral disintegrating tablets |
| 721 | 1 | 0.01 | partha saha ampicillin trihydrate chitos... |
| 722 | 1 | 0.01 | dsc analysis of chlorinated chitosan |
| 723 | 1 | 0.01 | dose of methionine in ischemia / reperfu... |
| 724 | 1 | 0.01 | calculate concentration using e1% 1cm |
| 725 | 1 | 0.01 | disadvantages of nanotechnology in drug ... |
| 726 | 1 | 0.01 | http://www.tjpr.org/vol13_no1/2014_13_1_... |
| 727 | 1 | 0.01 | patient perception of pharm reps |
| 728 | 1 | 0.01 | tropic. j .pharm. res. |
| 729 | 1 | 0.01 | transdermal enhancer |
| 730 | 1 | 0.01 | transdermal drug delivery systems pdf |
| 731 | 1 | 0.01 | preparation and evaluation of metformin |
| 732 | 1 | 0.01 | stability indicating method |
| 733 | 1 | 0.01 | danger of indiscriminate use of antibact... |
| 734 | 1 | 0.01 | coagclinic manual |
| 735 | 1 | 0.01 | controlled drug delivery system |
| 736 | 1 | 0.01 | chitosan |
| 737 | 1 | 0.01 | http://www.tjpr.org/vol13_no2/2014_13_2_... |
| 738 | 1 | 0.01 | n'guessan jean david email |
| 739 | 1 | 0.01 | orally disintegrating tablets guidance |
| 740 | 1 | 0.01 | physical properties of metronidazole |
| 741 | 1 | 0.01 | pharmacokinetic study |
| 742 | 1 | 0.01 | molded odt tablets |
| 743 | 1 | 0.01 | permeation thrugh skin including mechani... |
| 744 | 1 | 0.01 | www sciences pharmaceutique cocody |
| 745 | 1 | 0.01 | crosspovidone design |
| 746 | 1 | 0.01 | diuretic test method |
| 747 | 1 | 0.01 | what is the name of the regulatory body ... |
| 748 | 1 | 0.01 | reopical j of pharma research |
| 749 | 1 | 0.01 | positive ana, but c3 c4 normal |
| 750 | 1 | 0.01 | study to assess traditional application ... |
| 751 | 1 | 0.01 | abstract of blumea balsamifera l |
| 752 | 1 | 0.01 | azhar et al role of pharmacist in pakist... |
| 753 | 1 | 0.01 | insulin chitosan |
| 754 | 1 | 0.01 | cyclidextrin simvastatin dsc |
| 755 | 1 | 0.01 | hpmc coating solution sticking |
| 756 | 1 | 0.01 | anthony onyekweli |
| 757 | 1 | 0.01 | transdermal drug delivary system pdf |
| 758 | 1 | 0.01 | tropical journal of pharmac |
| 759 | 1 | 0.01 | c3 serum espn |
| 760 | 1 | 0.01 | formulation and evaluation of anti arthr... |
| 761 | 1 | 0.01 | coating of multiparticulate |
| 762 | 1 | 0.01 | bp online and suppositories |
| 763 | 1 | 0.01 | pharma validation |
| 764 | 1 | 0.01 | stability study of bilayer tablets |
| 765 | 1 | 0.01 | therapeutic uses of artocarpus altilis |
| 766 | 1 | 0.01 | penetration enhancers in pharmacy |
| 767 | 1 | 0.01 | methods hydro-alcoholic extraction |
| 768 | 1 | 0.01 | water soluble polymer used in preparatio... |
| 769 | 1 | 0.01 | www.tjpr.org |
| 770 | 1 | 0.01 | dose of gentamicin injection in rabbits |
| 771 | 1 | 0.01 | c3 in lupus |
| 772 | 1 | 0.01 | gc-ms oil |
| 773 | 1 | 0.01 | sample protocol in pharmaceutical valida... |
| 774 | 1 | 0.01 | public awareness about community pharmac... |
| 775 | 1 | 0.01 | research work on maclean toothpaste pdf |
| 776 | 1 | 0.01 | abstracts on awareness of malaria in urb... |
| 777 | 1 | 0.01 | waer soluble permeation enhancers |
| 778 | 1 | 0.01 | alp level in serum during gentamicin ind... |
| 779 | 1 | 0.01 | blumea balsamifera |
| 780 | 1 | 0.01 | mohaghegh ardabili university and gas ch... |
| 781 | 1 | 0.01 | low serum complement and glomerulonephri... |
| 782 | 1 | 0.01 | international journal of pharmacy and ph... |
| 783 | 1 | 0.01 | lab result total complement level |
| 784 | 1 | 0.01 | effect of disintegration time on quality... |
| 785 | 1 | 0.01 | complete c4 serum |
| 786 | 1 | 0.01 | hadeel zayyat |
| 787 | 1 | 0.01 | how to communicate wait time in hospital... |
| 788 | 1 | 0.01 | signicificance of fast disintegration ti... |
| 789 | 1 | 0.01 | suraiya "@hotmail.com" |
| 790 | 1 | 0.01 | antioxidant, iron-chelating and anti-glu... |
| 791 | 1 | 0.01 | 74 c4 compliment |
| 792 | 1 | 0.01 | anti-hiv effect of liposomes bearing cxc... |
| 793 | 1 | 0.01 | bilayer tablet excipient list |
| 794 | 1 | 0.01 | complement c4 if it is high |
| 795 | 1 | 0.01 | vanguard pharmaceutical machinery harnes... |
| 796 | 1 | 0.01 | utility of tablet silliver |
| 797 | 1 | 0.01 | stability of ticagrelor |
| 798 | 1 | 0.01 | soheyla honary, hamed barabadi, eshrat g... |
| 799 | 1 | 0.01 | oral fast dispersing dosage forms |
| 800 | 1 | 0.01 | nanotechnology in parasitic diseases |
| 801 | 1 | 0.01 | nauclea latifolio |
| 802 | 1 | 0.01 | role of biotechnology in pharmacy |
| 803 | 1 | 0.01 | silymarin brands in nigeria |
| 804 | 1 | 0.01 | mahibub aman shah |
| 805 | 1 | 0.01 | impact factor of trop j pharm res |
| 806 | 1 | 0.01 | what is c3 and c4 |
| 807 | 1 | 0.01 | pharmacotherapeutic group of vitamin b c... |
| 808 | 1 | 0.01 | pdf industrial quality control checks d... |
| 809 | 1 | 0.01 | pharmaceutical journals on flavonoids |
| 810 | 1 | 0.01 | stevia carbohydrate absorption |
| 811 | 1 | 0.01 | nitric oxide synthase activity measureme... |
| 812 | 1 | 0.01 | evaluation of permeation enhancers on tr... |
| 813 | 1 | 0.01 | brucellosis control in saudi arabia |
| 814 | 1 | 0.01 | how to avoid hiv |
| 815 | 1 | 0.01 | research article toothpaste formulation |
| 816 | 1 | 0.01 | serum complement levels in lupus nephrit... |
| 817 | 1 | 0.01 | asystematic review on tb diagnostic dela... |
| 818 | 1 | 0.01 | dsc of dicyclomine |
| 819 | 1 | 0.01 | atherosclerosis rats |
| 820 | 1 | 0.01 | antipyretic study |
| 821 | 1 | 0.01 | an overview of pharmaceutical validation |
| 822 | 1 | 0.01 | asparaginase isolation & purification |
| 823 | 1 | 0.01 | imultiparticulate sydtem?q=imultiparticu... |
| 824 | 1 | 0.01 | eldin dx cyrup |
| 825 | 1 | 0.01 | flash dissolve (zydis) wafer |
| 826 | 1 | 0.01 | pharmaceuticals care for home care servi... |
| 827 | 1 | 0.01 | pharmacy practice in malaysia 2013 filet... |
| 828 | 1 | 0.01 | kumu injection |
| 829 | 1 | 0.01 | http://www.tjpr.org/vol13_no1/2014_13_1_... |
| 830 | 1 | 0.01 | elevated c3 and c4 autoimmune |
| 831 | 1 | 0.01 | docs |
| 832 | 1 | 0.01 | fdc india ayyappa |
| 833 | 1 | 0.01 | pharma facility qualification courses |
| 834 | 1 | 0.01 | 4ea1ce54fe0a22b9eb70295254da7553 |
| 835 | 1 | 0.01 | design and evaluation of colon specific ... |
| 836 | 1 | 0.01 | stability indicating hplc methods for dr... |
| 837 | 1 | 0.01 | significant of raised c3 level in blood |
| 838 | 1 | 0.01 | pdf chemical properties of active pharma... |
| 839 | 1 | 0.01 | le guo wei jiangnan university |
| 840 | 1 | 0.01 | penetration enhancer ureum |
| 841 | 1 | 0.01 | prepration and evaluation of self pore ... |
| 842 | 1 | 0.01 | tropical j of pharmaceutical resarch |
| 843 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
| 844 | 1 | 0.01 | "su zr" |
| 845 | 1 | 0.01 | advantages of multi particulate system |
| 846 | 1 | 0.01 | tetrapleura tetraptera on bacteria infec... |
| 847 | 1 | 0.01 | release behaviour chitosan |
| 848 | 1 | 0.01 | kh2po4 in water dispersible granule |
| 849 | 1 | 0.01 | is senokot laxative square available in ... |
| 850 | 1 | 0.01 | liquefaction time apparatus erweka |
| 851 | 1 | 0.01 | dmso transdermal |
| 852 | 1 | 0.01 | how is aframomum melagueta extracted |
| 853 | 1 | 0.01 | increase level of serum complement |
| 854 | 1 | 0.01 | advantages of multiparticulated drug?q=a... |
| 855 | 1 | 0.01 | tjpr.php |
| 856 | 1 | 0.01 | tropical journal |
| 857 | 1 | 0.01 | pharmaceutical process monitoring |
| 858 | 1 | 0.01 | pdf cisplatin induced acute renal failur... |
| 859 | 1 | 0.01 | research article on nanoparticle cefixim... |
| 860 | 1 | 0.01 | c3 in sle |
| 861 | 1 | 0.01 | african journal of biotechnology science... |
| 862 | 1 | 0.01 | chemical penetration enhansers |
| 863 | 1 | 0.01 | dutsadee chinnapun |
| 864 | 1 | 0.01 | cmrc@ajums.ac.ir loc:us |
| 865 | 1 | 0.01 | causes of low c3 complement levels |
| 866 | 1 | 0.01 | c3 systemic lupus erythematosus |
| 867 | 1 | 0.01 | causes of low c4 but normal c3 |
| 868 | 1 | 0.01 | thonningia sanguinea health benefits |
| 869 | 1 | 0.01 | trop j pharm res impact factor |
| 870 | 1 | 0.01 | ayoola method dpph |
| 871 | 1 | 0.01 | omeprazole spectrophotometric |
| 872 | 1 | 0.01 | hunteria zeylanica tradisional use |
| 873 | 1 | 0.01 | ethnobotany a methods manual pdf |
| 874 | 1 | 0.01 | multidrug resistance of e.coli against m... |
| 875 | 1 | 0.01 | tropical journel of pharmacitical resear... |
| 876 | 1 | 0.01 | reference product for new orally disinte... |
| 877 | 1 | 0.01 | stevia plant extract pdf |
| 878 | 1 | 0.01 | vijay sharma b.n pharmacy college artica... |
| 879 | 1 | 0.01 | filetype:pdf aphanamixis polystachya |
| 880 | 1 | 0.01 | castor extraction study.pdf |
| 881 | 1 | 0.01 | bicuculline dose in experiments |
| 882 | 1 | 0.01 | vk sharma1*, a bhattacharya2, a kumar3 a... |
| 883 | 1 | 0.01 | types of formulation of drugs f1 |
| 884 | 1 | 0.01 | anticonvulsion activity pdf |
| 885 | 1 | 0.01 | antiepileptic crude drug |
| 886 | 1 | 0.01 | comparison of tdm in different hospitals... |
| 887 | 1 | 0.01 | cefuroxime axetil bcs |
| 888 | 1 | 0.01 | dye reduction test used for detecting an... |
| 889 | 1 | 0.01 | sbe nacl |
| 890 | 1 | 0.01 | nebivolol polymorphism |
| 891 | 1 | 0.01 | quality assesment of different sulphadox... |
| 892 | 1 | 0.01 | microencapsulated tramadol and acetamini... |
| 893 | 1 | 0.01 | izzet@imteks.net loc:us |
| 894 | 1 | 0.01 | medical/pharmaceutical science/faculty o... |
| 895 | 1 | 0.01 | approaches for breaking the barriers of ... |
| 896 | 1 | 0.01 | actinomycetes antibiotic producers |
| 897 | 1 | 0.01 | c4 lupus |
| 898 | 1 | 0.01 | facility qualification validation solid ... |
| 899 | 1 | 0.01 | validation related to pharma |
| 900 | 1 | 0.01 | saudi arabia kfupm@yahoo.com |
| 901 | 1 | 0.01 | ropical journal of pharmaceutical resear... |
| 902 | 1 | 0.01 | stability indicating hplc method |
| 903 | 1 | 0.01 | advantage of multiparticulte dosage form |
| 904 | 1 | 0.01 | advantages of multiparticulated drug |
| 905 | 1 | 0.01 | caffeine with antibiotics |
| 906 | 1 | 0.01 | leaves of terminelia arjuna pdf |
| 907 | 1 | 0.01 | ideal conc of mannitol in tablet |
| 908 | 1 | 0.01 | effects of azone on skin permeability |
| 909 | 1 | 0.01 | article on water extract of boerhaavia d... |
| 910 | 1 | 0.01 | c3 c4 level in sle |
| 911 | 1 | 0.01 | plants used for treating cholera |
| 912 | 1 | 0.01 | low complement level |
| 913 | 1 | 0.01 | leaf extraction pandan |
| 914 | 1 | 0.01 | morinda morindoides |
| 915 | 1 | 0.01 | tropical joyrnal of pharmaceutical |
| 916 | 1 | 0.01 | recent articles on causative agents of u... |
| 917 | 1 | 0.01 | relevance of a community pharmacist |
| 918 | 1 | 0.01 | validation drugs |
| 919 | 1 | 0.01 | literature review on. odt |
| 920 | 1 | 0.01 | c3c,c4 |
| 921 | 1 | 0.01 | biochemical effect of scar healing |
| 922 | 1 | 0.01 | phytosterol |
| 923 | 1 | 0.01 | non sterile solid drug product pharma m... |
| 924 | 1 | 0.01 | what is penetration drug |
| 925 | 1 | 0.01 | process validatyion pharmaceutical |
| 926 | 1 | 0.01 | physical and chemical properties of metr... |
| 927 | 1 | 0.01 | nanoencapsulation of drug by solvent eva... |
| 928 | 1 | 0.01 | low c3 and c4 with positive jo-1 |
| 929 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
| 930 | 1 | 0.01 | transdermal drug delivery system review ... |
| 931 | 1 | 0.01 | use of arthocleista nobilis and chroysop... |
| 932 | 1 | 0.01 | wangbang insulin |
| 933 | 1 | 0.01 | gc-mass for essential oil |
| 934 | 1 | 0.01 | ethanobotany pdf |
| 935 | 1 | 0.01 | buchanania lanzan activity |
| 936 | 1 | 0.01 | diseases that cause low c3 c4 complement |
| 937 | 1 | 0.01 | tropical journal of pharmacy |
| 938 | 1 | 0.01 | sukun.pdf/ |
| 939 | 1 | 0.01 | microsphere level of research |
| 940 | 1 | 0.01 | formulation and evaluation of nanopartic... |
| 941 | 1 | 0.01 | antimicrobial activities of thespesia po... |
| 942 | 1 | 0.01 | person's perceptions towards health resp... |
| 943 | 1 | 0.01 | nanofibers in drug delivery |
| 944 | 1 | 0.01 | pharmaceutical preparation of glipizide |
| 945 | 1 | 0.01 | sreenivasan, sasidharan . |
| 946 | 1 | 0.01 | drug delivery systems single multiple un... |
| 947 | 1 | 0.01 | different curve continuous variation met... |
| 948 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
| 949 | 1 | 0.01 | validation review article |
| 950 | 1 | 0.01 | chemical penetration enhancers |
| 951 | 1 | 0.01 | arginine and potassium |
| 952 | 1 | 0.01 | constituents of alstonia boonei |
| 953 | 1 | 0.01 | raised complement c4 |
| 954 | 1 | 0.01 | professor peter york of bradford univers... |
| 955 | 1 | 0.01 | sle c3 c4 |
| 956 | 1 | 0.01 | sight,alcohol,drug test for drivers in ... |
| 957 | 1 | 0.01 | 4-acetoxy azetidinone inindia journals r... |
| 958 | 1 | 0.01 | a stability-indicating lc method for |
| 959 | 1 | 0.01 | tropical journal of phar |
| 960 | 1 | 0.01 | soybean "@yahoo.co.in" |
| 961 | 1 | 0.01 | role of dendrimer in novel drug delivery... |
| 962 | 1 | 0.01 | solubility profile of eudragit |
| 963 | 1 | 0.01 | toothpaste formulation |
| 964 | 1 | 0.01 | snakes commonly found in nigeria |
| 965 | 1 | 0.01 | is silymarin available in nigeria |
| 966 | 1 | 0.01 | oral disinte tablet |
| 967 | 1 | 0.01 | edta-cs |
| 968 | 1 | 0.01 | complementc4 serum |
| 969 | 1 | 0.01 | how to investigate antidiarrhoeal activi... |
| 970 | 1 | 0.01 | in process control procedures in pharma |
| 971 | 1 | 0.01 | shinde et al article anti inflammatory ... |
| 972 | 1 | 0.01 | oral disintegrating tablets literature s... |
| 973 | 1 | 0.01 | mix boswellia with dmso on joints |
| 974 | 1 | 0.01 | poor knowledge about malaria in nigeria |
| 975 | 1 | 0.01 | complement c-3 |
| 976 | 1 | 0.01 | finite differences drug release |
| 977 | 1 | 0.01 | low c3 level |
| 978 | 1 | 0.01 | actinomycetes cells use as antibiotic |
| 979 | 1 | 0.01 | www.akanayoherbal.com |
| 980 | 1 | 0.01 | what does it mean to have low c3 and c4 ... |
| 981 | 1 | 0.01 | ticagrelor photodegradation |
| 982 | 1 | 0.01 | why want metformin extened releles melt ... |
| 983 | 1 | 0.01 | disintegrating and dissolving tablets |
| 984 | 1 | 0.01 | biopharmaceutical classification system ... |
| 985 | 1 | 0.01 | concentration ivermectin super |
| 986 | 1 | 0.01 | journal on official assay method for art... |
| 987 | 1 | 0.01 | laxative studies in plant extract with a... |
| 988 | 1 | 0.01 | formulation and evaluation of matrix mic... |
| 989 | 1 | 0.01 | chemical composition of stevia |
| 990 | 1 | 0.01 | 10.4314/tjpr.v10i6.10 |
| 991 | 1 | 0.01 | 4-fdc analysis hplc |
| 992 | 1 | 0.01 | decitabine hplc method |
| 993 | 1 | 0.01 | efficacy of toothpastes |
| 994 | 1 | 0.01 | osteoporosis disease inmalaysia |
| 995 | 1 | 0.01 | nanostructured drug delivery systems |
| 996 | 1 | 0.01 | microparticle by solvent evaporation met... |
| 997 | 1 | 0.01 | meloxycame formulation |
| 998 | 1 | 0.01 | modern uses of ethnobotany |
| 999 | 1 | 0.01 | skin penetration enhancers |
| 1000 | 1 | 0.01 | tablets and its types and preparations p... |
| 1001 | 1 | 0.01 | www.tjpr.org/vol2 no2/22editorial.htm |
| 1002 | 1 | 0.01 | nanoparticle+elicitor |
| 1003 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
| 1004 | 1 | 0.01 | tropical journal of pharma reserch |
| 1005 | 1 | 0.01 | types of milk products quality tests |
| 1006 | 1 | 0.01 | package validation review papers |
| 1007 | 1 | 0.01 | mouth dissolving tablets and orally disi... |
| 1008 | 1 | 0.01 | phytosterol |
| 1009 | 1 | 0.01 | quercus infectoria pdf |
| 1010 | 1 | 0.01 | formula for orodispersible tablets pdf |
| 1011 | 1 | 0.01 | abstracts on alkyd resin |
| 1012 | 1 | 0.01 | hygrophila spinosa medicinal uses |
| 1013 | 1 | 0.01 | high c4 levels |
| 1014 | 1 | 0.01 | ideal requirements for oral disintegrati... |
| 1015 | 1 | 0.01 | impact of nanoscience in healthcare deli... |
| 1016 | 1 | 0.01 | disintegration time of orally disintegra... |
| 1017 | 1 | 0.01 | complete c3 c4 |
| 1018 | 1 | 0.01 | drugs derived from okra |
| 1019 | 1 | 0.01 | bioavailability of carbamazepine pdf |
| 1020 | 1 | 0.01 | antimicrobial activity of tamarindus ind... |
| 1021 | 1 | 0.01 | antioxidant activity of balanites aegypt... |
| 1022 | 1 | 0.01 | colon targeted drug delivery with new po... |
| 1023 | 1 | 0.01 | drug shop and nigeria |
| 1024 | 1 | 0.01 | ebook on seperation of volatile componen... |
| 1025 | 1 | 0.01 | chalcone |
| 1026 | 1 | 0.01 | cefuroxime axetil & bcs |
| 1027 | 1 | 0.01 | commercially available antibiotics used ... |
| 1028 | 1 | 0.01 | skin penetrating agents |
| 1029 | 1 | 0.01 | a method for induction gentamicin of kid... |
| 1030 | 1 | 0.01 | pdfs for preparation and evaluation of m... |
| 1031 | 1 | 0.01 | multiple unit pellet system ppt |
| 1032 | 1 | 0.01 | journal of anti diabetic effects of curc... |
| 1033 | 1 | 0.01 | kim sung-jin, pharmacology, kyung hee |
| 1034 | 1 | 0.01 | nanotechnology in drug delivery |
| 1035 | 1 | 0.01 | pdf herbal medicine?q=pdf herbal medicin... |
| 1036 | 1 | 0.01 | high complement c4, serum |
| 1037 | 1 | 0.01 | eudragit rspo |
| 1038 | 1 | 0.01 | c3 and c4 diagnosis is what |
| 1039 | 1 | 0.01 | vidyasur @rediffmail.com |
| 1040 | 1 | 0.01 | different nigeria medicinal plants used ... |
| 1041 | 1 | 0.01 | indomethacin an anti inflammatory activi... |
| 1042 | 1 | 0.01 | how to extract plant using ethyl acetate |
| 1043 | 1 | 0.01 | http://www.tjpr.org/vol7_no3/939_dey.pdf |
| 1044 | 1 | 0.01 | low complement c3 and c4 causes |
| 1045 | 1 | 0.01 | orally disintegrating tablets hardness t... |
| 1046 | 1 | 0.01 | low c3 normal c4 lupus |
| 1047 | 1 | 0.01 | meloxicam stability studies |
| 1048 | 1 | 0.01 | dmso for penetration |
| 1049 | 1 | 0.01 | complements in lupus nephritis |
| 1050 | 1 | 0.01 | control release system |
| 1051 | 1 | 0.01 | formulation evaluation of effervescent t... |
| 1052 | 1 | 0.01 | ticagrelor hplc |
| 1053 | 1 | 0.01 | sulfadoxine analysis |
| 1054 | 1 | 0.01 | pharmaceutical biology homepage |
| 1055 | 1 | 0.01 | pre-validaiton experiments include |
| 1056 | 1 | 0.01 | tropical journal phar |
| 1057 | 1 | 0.01 | antimicrobial activity of ashoka plant |
| 1058 | 1 | 0.01 | carbopol gel , essential oil |
| 1059 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
| 1060 | 1 | 0.01 | the particle size for the preparation of... |
| 1061 | 1 | 0.01 | od tablets?q=od tablets |
| 1062 | 1 | 0.01 | nageen hussain dnase 1 |
| 1063 | 1 | 0.01 | nanotechnology,pdf |
| 1064 | 1 | 0.01 | pharmaceutical process validation |
| 1065 | 1 | 0.01 | osmotic tablets pdf |
| 1066 | 1 | 0.01 | pharmacy hospital system one gate abstra... |
| 1067 | 1 | 0.01 | green chemistry and sustainable developm... |
| 1068 | 1 | 0.01 | flemingia strobilifera health benefits |
| 1069 | 1 | 0.01 | decription of snake in nigeria |
| 1070 | 1 | 0.01 | antibacterial plants pdf file |
| 1071 | 1 | 0.01 | drug delivery system by nanotechnology |
| 1072 | 1 | 0.01 | metronidazole profile |
| 1073 | 1 | 0.01 | penetration uvc µm tissus |
| 1074 | 1 | 0.01 | serum c3 |
| 1075 | 1 | 0.01 | protein extraction from senna occidental... |
| 1076 | 1 | 0.01 | gc ms analysis of essential oils |
| 1077 | 1 | 0.01 | chinese medicine hong kong chromatograph... |
| 1078 | 1 | 0.01 | conclusion of dregea volubilis benth.ex.... |
| 1079 | 1 | 0.01 | http://www.tjpr.org/vol13_no1/2014_13_1_... |
| 1080 | 1 | 0.01 | leishmania and cancer |
| 1081 | 1 | 0.01 | solubility+drug |
| 1082 | 1 | 0.01 | senna occidentalis alkaloids |
| 1083 | 1 | 0.01 | p.koca@farmanorm.com.tr loc:us |
| 1084 | 1 | 0.01 | pdf files on gallic acid |
| 1085 | 1 | 0.01 | activité anticonvulsive |
| 1086 | 1 | 0.01 | witepsol displacement factor |
| 1087 | 1 | 0.01 | &sa=search |
| 1088 | 1 | 0.01 | ardon's method |
| 1089 | 1 | 0.01 | asaraginase solid state fermenytation |
| 1090 | 1 | 0.01 | halth complication associated with inade... |
| 1091 | 1 | 0.01 | analytical methods for mefanamic acid,dr... |
| 1092 | 1 | 0.01 | synthesis of diclofenac |
| 1093 | 1 | 0.01 | surfactant span tween hplc quantitation |
| 1094 | 1 | 0.01 | true density of paracetamol granules pre... |
| 1095 | 1 | 0.01 | thyme oil topical formulation |
| 1096 | 1 | 0.01 | wound healing od quercus infectoria |
| 1097 | 1 | 0.01 | parcetamol +index |
| 1098 | 1 | 0.01 | literature review of fast disintegrating... |
| 1099 | 1 | 0.01 | microsponge novel drug delivery |
| 1100 | 1 | 0.01 | sarawoot palipoch |
| 1101 | 1 | 0.01 | pdf: rivew on control drug dilevary syst... |
| 1102 | 1 | 0.01 | pharmacy forms reasons for prescription ... |
| 1103 | 1 | 0.01 | trans dermal pdf file |
| 1104 | 1 | 0.01 | carbomer gel formulation |
| 1105 | 1 | 0.01 | antipyretic study abou plant extract usi... |
| 1106 | 1 | 0.01 | study in difficulty in swallowing conven... |
| 1107 | 1 | 0.01 | pharm. res. submission |
| 1108 | 1 | 0.01 | release procedure of production process ... |
| 1109 | 1 | 0.01 | taha aa naji, |
| 1110 | 1 | 0.01 | apoptosis ficus extract pdf |
| 1111 | 1 | 0.01 | gcms pdf download' |
| 1112 | 1 | 0.01 | gastroretentive drug delivery system |
| 1113 | 1 | 0.01 | complement c4 levels |
| 1114 | 1 | 0.01 | first time p**** penetrated by a c*** |
| 1115 | 1 | 0.01 | microsphere chitosan alginate degradatio... |
| 1116 | 1 | 0.01 | hadeel h. zayyat |
| 1117 | 1 | 0.01 | nanoparticles dendrimers - drug delivery... |
| 1118 | 1 | 0.01 | noman.saghir@pktcl.com loc:us |
| 1119 | 1 | 0.01 | solubility of cefuroxime axetis |
| 1120 | 1 | 0.01 | research journals in pharmaceutics |
| 1121 | 1 | 0.01 | high complement c4 serum |
| 1122 | 1 | 0.01 | formulation and evaluation of glibenclam... |
| 1123 | 1 | 0.01 | osmotic pump tablet pdf |
| 1124 | 1 | 0.01 | traditional medicine in nigeria (pdf) |
| 1125 | 1 | 0.01 | antimicrobial efficacy of different toot... |
| 1126 | 1 | 0.01 | a review journal of tablet dosage form |
| 1127 | 1 | 0.01 | azone enhancer |
| 1128 | 1 | 0.01 | alpha lipoic acid nephrotoxicity |
| 1129 | 1 | 0.01 | antibiotics interaction pdf |
| 1130 | 1 | 0.01 | test tube phytochemical screening |
| 1131 | 1 | 0.01 | stevia and inflammation pdf |
| 1132 | 1 | 0.01 | what is the important of pharmacist to t... |
| 1133 | 1 | 0.01 | breast cancer stem cell and oct-4 |
| 1134 | 1 | 0.01 | antiepileptic activity |
| 1135 | 1 | 0.01 | chitosan lipophilic microparticle filety... |
| 1136 | 1 | 0.01 | low c3 c4 |
| 1137 | 1 | 0.01 | http://www.tjpr.org/vol8_no4/2009_8_4_1_... |
| 1138 | 1 | 0.01 | how to correct for thermal energy in qua... |
| 1139 | 1 | 0.01 | dry granulation slugging aspirin |
| 1140 | 1 | 0.01 | below normal result for c3 |
| 1141 | 1 | 0.01 | effect of plant extract on total protein... |
| 1142 | 1 | 0.01 | gentamisin pdf |
| 1143 | 1 | 0.01 | polymer coating of multiparticulates for... |
| 1144 | 1 | 0.01 | maxwell adibe occupational |
| 1145 | 1 | 0.01 | normal range of c3 and c4 |
| 1146 | 1 | 0.01 | low complement c3 lupus levels |
| 1147 | 1 | 0.01 | m ferdosian |
| 1148 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
| 1149 | 1 | 0.01 | review paper on transdermal drug deliver... |
| 1150 | 1 | 0.01 | tropical j pharmaceutical research |
| 1151 | 1 | 0.01 | abstract for volatile oil based gel |
| 1152 | 1 | 0.01 | antipyretic activity pdf |
| 1153 | 1 | 0.01 | a review on process vallidation pdf |
| 1154 | 1 | 0.01 | 6. nanoparticles – a review : mohanraj... |
| 1155 | 1 | 0.01 | why is dispensing medicine propely impor... |
| 1156 | 1 | 0.01 | method involved in pharnmaceutical valid... |
| 1157 | 1 | 0.01 | rapid colorimetric assay of diclofenac s... |
| 1158 | 1 | 0.01 | solid state fermentation for actinomycet... |
| 1159 | 1 | 0.01 | journal of pharmacy research |
| 1160 | 1 | 0.01 | antibacterial properties extracts |
| 1161 | 1 | 0.01 | low c4 and normal c3 |
| 1162 | 1 | 0.01 | oral desingrating.tablet |
| 1163 | 1 | 0.01 | tropical journal of pharmaceutical scien... |
| 1164 | 1 | 0.01 | to study about in patient waiting time i... |
| 1165 | 1 | 0.01 | pharmaceutical care pdf |
| 1166 | 1 | 0.01 | papers or article on orodispersible tabl... |
| 1167 | 1 | 0.01 | pharmaceutical journals those pay to aut... |
| 1168 | 1 | 0.01 | madhusudhana reddy induri |
| 1169 | 1 | 0.01 | microsperes pdf |
| 1170 | 1 | 0.01 | curcumin has protective role via nitric ... |
| 1171 | 1 | 0.01 | controlled release+pharmaceutics journal |
| 1172 | 1 | 0.01 | s.baghalian@iauh.ac.ir |
| 1173 | 1 | 0.01 | effect of coat processing on drug releas... |
| 1174 | 1 | 0.01 | determinants of caesarean risk factor in... |
| 1175 | 1 | 0.01 | increased c4 level |
| 1176 | 1 | 0.01 | studies on wound healing herbal |
| 1177 | 1 | 0.01 | pharmaceutical process validation pdf |
| 1178 | 1 | 0.01 | orally disintegrating tablets first pass... |
| 1179 | 1 | 0.01 | herbal cosmeceuticals for photoprotectio... |
| 1180 | 1 | 0.01 | low c normal c4 |
| 1181 | 1 | 0.01 | ms & low c3 & c4 |
| 1182 | 1 | 0.01 | manufacturing quality system data migrat... |
| 1183 | 1 | 0.01 | nigeria pharmacists south africa |
| 1184 | 1 | 0.01 | matrix release tablets of quetiapine by ... |
| 1185 | 1 | 0.01 | http://www.tjpr.org/vol13_no1/2014_13_1_... |
| 1186 | 1 | 0.01 | diazepam treatment in mice seizures |
| 1187 | 1 | 0.01 | antioxidant activity of medicinal plants |
| 1188 | 1 | 0.01 | eudragit |
| 1189 | 1 | 0.01 | noval mucoadhesive polymer for vagina |
| 1190 | 1 | 0.01 | na carboxy methyl cellulose to prepare b... |
| 1191 | 1 | 0.01 | nano based drug delivery |
| 1192 | 1 | 0.01 | pte j w watson 4417 3/4 east lancs |
| 1193 | 1 | 0.01 | quercetin+prostate cancer+pdf |
| 1194 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
| 1195 | 1 | 0.01 | thioglycolic acid vaccine conjugation |
| 1196 | 1 | 0.01 | stability study of bilayer tablets |
| 1197 | 1 | 0.01 | meloxicam tablet solubility enhancement |
| 1198 | 1 | 0.01 | journal of turmeric extract cream formul... |
| 1199 | 1 | 0.01 | kumar et al antimicrobial activity in 61... |
| 1200 | 1 | 0.01 | out patients perception of service quali... |
| 1201 | 1 | 0.01 | bilogical evaluation of diuretic drugs p... |
| 1202 | 1 | 0.01 | antimicrobial evaluation plant drugs |
| 1203 | 1 | 0.01 | global prevalence of self medication wit... |
| 1204 | 1 | 0.01 | chitosan based film |
| 1205 | 1 | 0.01 | serum complement c3 c4 |
| 1206 | 1 | 0.01 | related literature about dispensing |
| 1207 | 1 | 0.01 | how to reduce the waiting patient's dela... |
| 1208 | 1 | 0.01 | picrotoxin dose for mechanism study on m... |
| 1209 | 1 | 0.01 | copper sulfate inhibitor |
| 1210 | 1 | 0.01 | wait time journal in pharmacy prescripti... |
| 1211 | 1 | 0.01 | antimicrobial activity of the leaves |
| 1212 | 1 | 0.01 | drotaverin ph 6.8 |
| 1213 | 1 | 0.01 | delta decalactone |
| 1214 | 1 | 0.01 | green chemistry research project in sout... |
| 1215 | 1 | 0.01 | asparaginase production |
| 1216 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
| 1217 | 1 | 0.01 | tropical j of pharma sci |
| 1218 | 1 | 0.01 | different types of drug delivery systems |
| 1219 | 1 | 0.01 | can lupus have c3 c4 normal |
| 1220 | 1 | 0.01 | comparison between reverse phase hplc me... |
| 1221 | 1 | 0.01 | drug delivery systems pdf |
| 1222 | 1 | 0.01 | eudragit rs coating solution ethanol |
| 1223 | 1 | 0.01 | dmf mobile phase |
| 1224 | 1 | 0.01 | advantages of orally disintegrating tabl... |
| 1225 | 1 | 0.01 | tropical journal pharmacetyc |
| 1226 | 1 | 0.01 | wetting time of tablets |
| 1227 | 1 | 0.01 | benefits of multiparticulate drug delive... |
| 1228 | 1 | 0.01 | molecular wt of chitosan |
| 1229 | 1 | 0.01 | microcapsulation preparaton pdf by emult... |
| 1230 | 1 | 0.01 | kneading method of solid dispersion |
| 1231 | 1 | 0.01 | preparation and evaluation of matrix tab... |
| 1232 | 1 | 0.01 | ppar and their use in providing health p... |
| 1233 | 1 | 0.01 | prehypertension in nigeria |
| 1234 | 1 | 0.01 | prevalence of microbial contamination of... |
| 1235 | 1 | 0.01 | pdf,mucin |
| 1236 | 1 | 0.01 | paper resistan urine |
| 1237 | 1 | 0.01 | mucoadhesive |
| 1238 | 1 | 0.01 | multiparticulate system |
| 1239 | 1 | 0.01 | cefuroxime axetil solubility in methyle... |
| 1240 | 1 | 0.01 | dose dumping as per controlled drug deli... |
| 1241 | 1 | 0.01 | isoproterenol glucose mice |
| 1242 | 1 | 0.01 | http://www.tjpr.org/vol7_no4/743_hussain... |
| 1243 | 1 | 0.01 | kellar kiliani's test for glycosides in ... |
| 1244 | 1 | 0.01 | sukun.pdf/#gsc.tab=0 |
| 1245 | 1 | 0.01 | phytosterol in growth performance of ani... |
| 1246 | 1 | 0.01 | pharmaceutical process validation book p... |
| 1247 | 1 | 0.01 | propylene glycol as a penetration enhanc... |
| 1248 | 1 | 0.01 | acetophenone charmm force field |
| 1249 | 1 | 0.01 | complex of chalcone+2014 |
| 1250 | 1 | 0.01 | compliment c lupus |
| 1251 | 1 | 0.01 | sle c3 and c4 |
| 1252 | 1 | 0.01 | pharmaceutical technology odt |
| 1253 | 1 | 0.01 | preformulation of ndds |
| 1254 | 1 | 0.01 | tjpr.org |
| 1255 | 1 | 0.01 | fast release agent used in capsule |
| 1256 | 1 | 0.01 | herbal sugar#q=a pdf file on stevia |
| 1257 | 1 | 0.01 | cytotoxicity of mango leaf extracts |
| 1258 | 1 | 0.01 | chrysophyllum albidum.pdf |
| 1259 | 1 | 0.01 | dmso drug delivery |
| 1260 | 1 | 0.01 | normal range of complement c3 |
| 1261 | 1 | 0.01 | increased total serum complement in dise... |
| 1262 | 1 | 0.01 | pdf format of does gentamacin causes nep... |
| 1263 | 1 | 0.01 | permeation enhancer |
| 1264 | 1 | 0.01 | amson pharma silymarin |
| 1265 | 1 | 0.01 | vitamin c in balanite aegyptiaca |
| 1266 | 1 | 0.01 | serum complement concentration |
| 1267 | 1 | 0.01 | serm |
| 1268 | 1 | 0.01 | tropical journal of pharmaceutical micro... |
| 1269 | 1 | 0.01 | filetype:pdf pandanus amaryllifolius |
| 1270 | 1 | 0.01 | fluoroquinolone structure xray |
| 1271 | 1 | 0.01 | permeation enhancer substances |
| 1272 | 1 | 0.01 | assay validation during phase 2 pharmace... |
| 1273 | 1 | 0.01 | antimicrobial activity of garcinia kola |
| 1274 | 1 | 0.01 | characterisation of solid dispersion |
| 1275 | 1 | 0.01 | recent journals on stability testing of ... |
| 1276 | 1 | 0.01 | factors affecting permeation of drug thr... |
| 1277 | 1 | 0.01 | nigeria medicinal plant used in the mana... |
| 1278 | 1 | 0.01 | anticonvulsant.pdf papers |
| 1279 | 1 | 0.01 | c4 level for person with lupus |
| 1280 | 1 | 0.01 | phytosterols on growth performance |
| 1281 | 1 | 0.01 | nano technology drug delivery news |
| 1282 | 1 | 0.01 | new formulation diclofenac intravenous |
| 1283 | 1 | 0.01 | medicinal plants body weight of rats |
| 1284 | 1 | 0.01 | low c4 |
| 1285 | 1 | 0.01 | methods of enhancement of transdermal dr... |
| 1286 | 1 | 0.01 | mudassar iqbal agricultural chemistry |
| 1287 | 1 | 0.01 | transdermal |
| 1288 | 1 | 0.01 | actinomycetes isolate by well plate meth... |
| 1289 | 1 | 0.01 | prevalence and smoking and malaysia |
| 1290 | 1 | 0.01 | stevia nutritional composition |
| 1291 | 1 | 0.01 | increase complement c4 |
| 1292 | 1 | 0.01 | an |
| 1293 | 1 | 0.01 | ipqc introduction pdf |
| 1294 | 1 | 0.01 | is alu safe for a pregnant to cure malar... |
| 1295 | 1 | 0.01 | average number of atesunate sold per ann... |
| 1296 | 1 | 0.01 | s.baghalian@iauh.ac.ir loc:us |
| 1297 | 1 | 0.01 | transdermal drug delivery system review ... |
| 1298 | 1 | 0.01 | malaria and the rural community |
| 1299 | 1 | 0.01 | isolation of flavonoid from castor oil ... |
| 1300 | 1 | 0.01 | low c3 and proteinuria |
| 1301 | 1 | 0.01 | munavvar zubaid |
| 1302 | 1 | 0.01 | microbiological quality of toothpaste |
| 1303 | 1 | 0.01 | odt tablets |
| 1304 | 1 | 0.01 | garlic diuretic research |
| 1305 | 1 | 0.01 | full blood count reference range in mala... |
| 1306 | 1 | 0.01 | c3 c4 complement measure method |
| 1307 | 1 | 0.01 | boerhaavia diffusa extract |
| 1308 | 1 | 0.01 | firmulation and evaluation of cinnariz... |
| 1309 | 1 | 0.01 | pharma process validation |
| 1310 | 1 | 0.01 | how can hunteria umbellata cure fever |
| 1311 | 1 | 0.01 | nanotechnology in drug design |
| 1312 | 1 | 0.01 | interaction between penicillin and staph... |
| 1313 | 1 | 0.01 | evaluation of dental films periodontitis |
| 1314 | 1 | 0.01 | dimethylformamide and tlc |
| 1315 | 1 | 0.01 | ethnobotany today |
| 1316 | 1 | 0.01 | wood extracts |
| 1317 | 1 | 0.01 | venom activity of gloriosa superba root |
| 1318 | 1 | 0.01 | bladder cancer cell mdr-1 high expressio... |
| 1319 | 1 | 0.01 | carbomer gel base formulation |
| 1320 | 1 | 0.01 | • kn varalakshmi, cg sangeetha, sp pra... |
| 1321 | 1 | 0.01 | cases of irrational uses of drugs among ... |
| 1322 | 1 | 0.01 | solventevaporation method |
| 1323 | 1 | 0.01 | scope.educ.washington.edu/malaria |
| 1324 | 1 | 0.01 | nanotechnology for topical and transderm... |
| 1325 | 1 | 0.01 | tropical pharmaceutical journal |
| 1326 | 1 | 0.01 | sesamin ppar agonist |
| 1327 | 1 | 0.01 | rationale of tablet in capsule technolog... |
| 1328 | 1 | 0.01 | nutrition in stevia leaf 100 gram dried |
| 1329 | 1 | 0.01 | isolation identification of antibiotic p... |
| 1330 | 1 | 0.01 | paracetamol microsphere pdf |
| 1331 | 1 | 0.01 | pdf on the future of nigerian pharmacist... |
| 1332 | 1 | 0.01 | challenges with orally disintegrating ta... |
| 1333 | 1 | 0.01 | cress lepidium sativum filetype:pdf |
| 1334 | 1 | 0.01 | effect of corynoline isolated from coryd... |
| 1335 | 1 | 0.01 | composition of silymarin from milk this... |
| 1336 | 1 | 0.01 | conclusion for release of drug from tran... |
| 1337 | 1 | 0.01 | flavonoides from centaurea iberica |
